Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

DIAGNOS poised for parabolic move as first of new cardio AI Applications comes to market

DIAGNOS Inc. (TSX-V: ADK) (OTCQB: DGNOF) (Frankfurt: 4D4) is a Canadian-based healthcare software technology company that pioneered ' C omputer A ssisted R etinal A nalysis' (CARA), applying artificial intelligence to non-invasively test, identify, and classify patients a...
James O'Rourke | May 5, 2020 |

ArQule Shares Double on Proposed $2.7 Billion Tender Offer from Merck

ArQule Inc. shares traded more than 100% higher today after the company entered into definitive agreement to be acquired by a Merck subsidiary company for $20 per share. The deal is valued at $2.7 billion and is expected to close in the early part of Q1/20. This morni...
Streetwise Reports | December 10, 2019 |

ChemoCentryx Shares Spike 300% on Phase 3 ANCA Vasculitis Trial Results

Shares of ChemoCentryx Inc. opened greater than 330% higher today after the firm reported positive topline data from its pivotal Phase 3 ADVOCATE trial of Avacopan in treatment of ANCA-associated vasculitis. After the U.S. markets closed yesterday, ChemoCentryx Inc. ...
Streetwise Reports | November 27, 2019 |

NGM Biopharma Shares Rise on Positive Topline Data from Phase 2 NASH Trial

Shares of NGM Biopharmaceuticals reached a new 52-week intraday high price after the company posted positive topline data from Cohort 4 of its Phase 2 study of aldafermin in NASH Patients. On a day when world financial markets traded lower across the board, ...
Streetwise Reports | February 25, 2020 |

Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study

Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients. Clinical-stage biotechnology...
Streetwise Reports | July 2, 2020 |

Fandom Sports Set to Launch NFT Marketplace Including Gamification & Rewards

THE PLATFORM PLANS TO REWARD FAN ENGAGEMENT WITH UTILITY AND UNIQUE CUSTOM NFTS Fandom Sports Media Corporation ( CSE: FDM , Forum ) , a Vancouver-based gaming and entertainment company, is all set to launch its all-ages gamification platform that will reward fan engageme...
Chris Thompson | April 5, 2022 |

A Deeper Look at a High-Grade Project in BC

(Click to play.) Affinity Metals Corp. ( TSX-V: AFF , Forum ) is engaged in the acquisition, exploration, and development of strategic metal deposits, including the Regal and West Timmins Gold projects and the prospective Windfall North Property in Quebec. ...
Featured Submission | May 3, 2022 |

Eminent Gold (TSXV:EMNT): Pursuing major gold discoveries in the great basin

Eminent Gold’s (TSXV:EMNT) overview video highlights their exciting four projects in Nevada, including a look at some never-before-seen opportunities.
John Ballem | October 14, 2022 |

Saskatchewan's own high-quality domestic diamond play

Star Diamond (TSX:DIAM) provides a tour of their facilities in Saskatchewan, including drilling equipment, kimberlite separation unit, drill core storage warehouse, Star-Orion South Diamond Project, bulk sample processing plant and more. Investment highlights: ...
Research | February 6, 2024 |

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. In a Jan. 13 research note, Dawson James Securities analyst Jason Kolbert reported that Daré Bioscience Inc. (DARE:NASDAQ) partnered with Bayer, the company beh...
Streetwise Reports | January 16, 2020 |
1 2 3 4 5 6 7 8 9 10 ...